The American Lobster Fishery Management Plan: An Assessment of Its Impact on the New Hampshire Lobster Industry

Exclusive fishery management jurisdiction between three and twelve nautical miles from the coast was granted to the Federal government by Congress in 1966. No federal regulations governing fishery management were ever promulgated, however. In 1972 an attempt was made to establish management regulations. Regional councils were formed to discuss industrial, managerial and scientific problems associated with fisheries within the territorial sea. Their success was limited. Not until the Fishery Conservation and ManagementAct of 1976 (PubIc Law 94-265) was enacted did a sound management structure exist at the federal level for fisheries regulation. This Act (FCMA) established a fishery conservation zone and an exclusive fishery management authority

Fertilizing No-Till Corn

Results of an experiment conducted in 1968 at Princeton, Kentucky on low phosphate soil showed that surface-applied phosphorus was sufficiently available to no-till corn to produce good yields. This experiment was repeated again in the 1969 growing season with the results well in line with those reported for 1968 in Agronomy Research (Misc. 377) pages 41-43

Voyager 2 Observations of Plasma and Pressure Pulses

This paper provides the latest data from Voyager 2 on plasma characteristics in the heliosheath including the observations of pressure waves in the plasma and particle data. Models and observations show that solar transients drive pressure waves through the heliosphere. Pressure pulses that could drive heliosheath waves are observed near the previous solar maximum upstream of the termination shock. We show that the most recent data is consistent with the presence of pressure waves and compare the heliosheath waves with the pressure increases in the heliosheath. The magnetic field is better correlated with density and galactic cosmic ray intensities in the supersonic solar wind than in the heliosheath. The galactic cosmic rays are correlated with the plasma and particles with a ~30-day lag in both the supersonic wind and heliosheath

Voyager 2 Observations Near the Heliopause

This paper discusses plasma characteristics in the heliosheath region before the heliopause (HP), at the HP, and in the very local interstellar medium (VLISM). The Voyager 2 (V2) HP was a sharp boundary where the radial plasma currents went to background levels. The radial flow speeds derived from 53-85 keV (V1) and 28-43 keV (V2) ion data decreased about 2 years (8 AU) before the HP at V1 and V2. A speed decrease was not observed by the V2 plasma instrument until 160 days (1.5 AU) before the HP crossing when V2 entered the plasma boundary layer where the plasma density and 28-43 keV ion intensity increased. We determine the HP orientation based on the plasma flow and magnetic field data and show these observations are consistent with models predicting a blunt HP. Variations are observed in the currents observed in the VLISM; roll data from this region clearly show the plasma instrument observes the interstellar plasma and may be consistent with larger than expected VLISM temperatures near the HP

Voyager 2 Observations Near the Heliopause

This paper discusses plasma characteristics in the heliosheath region before the heliopause (HP), at the HP, and in the very local interstellar medium (VLISM). The Voyager 2 (V2) HP was a sharp boundary where the radial plasma currents went to background levels. The radial flow speeds derived from 53-85 keV (V1) and 28-43 keV (V2) ion data decreased about 2 years (8 AU) before the HP at V1 and V2. A speed decrease was not observed by the V2 plasma instrument until 160 days (1.5 AU) before the HP crossing when V2 entered the plasma boundary layer where the plasma density and 28-43 keV ion intensity increased. We determine the HP orientation based on the plasma flow and magnetic field data and show these observations are consistent with models predicting a blunt HP. Variations are observed in the currents observed in the VLISM; roll data from this region clearly show the plasma instrument observes the interstellar plasma and may be consistent with larger than expected VLISM temperatures near the HP

Voyager 2 Observations of Plasma and Pressure Pulses

This paper provides the latest data from Voyager 2 on plasma characteristics in the heliosheath including the observations of pressure waves in the plasma and particle data. Models and observations show that solar transients drive pressure waves through the heliosphere. Pressure pulses that could drive heliosheath waves are observed near the previous solar maximum upstream of the termination shock. We show that the most recent data is consistent with the presence of pressure waves and compare the heliosheath waves with the pressure increases in the heliosheath. The magnetic field is better correlated with density and galactic cosmic ray intensities in the supersonic solar wind than in the heliosheath. The galactic cosmic rays are correlated with the plasma and particles with a ~30-day lag in both the supersonic wind and heliosheath

Comparison of electromagnetic and gravitational radiation: What we can learn about each from the other

We compare the nature of electromagnetic fields and gravitational fields in linearized general relativity. We carry out this comparison both mathematically and visually. In particular, the “lines of force” visualizations of electromagnetism are contrasted with the recently introduced tendex/vortex eigenline technique for visualizing gravitational fields. Specific solutions, visualizations, and comparisons are given for an oscillating point quadrupole source. Among the similarities illustrated are the quasistatic nature of the near fields, the transverse 1/r nature of the far fields, and the interesting intermediate field structures connecting these two limiting forms. Among the differences illustrated are the meaning of field line motion and of the flow of energy

Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men

<p>Recombinant human erythropoietin (rHuEpo) increases haemoglobin mass (Hbmass) and maximal oxygen uptake (v˙ O2 max).</p> <p>Purpose: This study defined the time course of changes in Hbmass, v˙ O2 max as well as running time trial performance following 4 weeks of rHuEpo administration to determine whether the laboratory observations would translate into actual improvements in running performance in the field.</p> <p>Methods: 19 trained men received rHuEpo injections of 50 IUNkg21 body mass every two days for 4 weeks. Hbmass was determined weekly using the optimized carbon monoxide rebreathing method until 4 weeks after administration. v˙ O2 max and 3,000 m time trial performance were measured pre, post administration and at the end of the study.</p> <p>Results: Relative to baseline, running performance significantly improved by ,6% after administration (10:3061:07 min:sec vs. 11:0861:15 min:sec, p,0.001) and remained significantly enhanced by ,3% 4 weeks after administration (10:4661:13 min:sec, p,0.001), while v˙ O2 max was also significantly increased post administration (60.765.8 mLNmin21Nkg21 vs. 56.066.2 mLNmin21Nkg21, p,0.001) and remained significantly increased 4 weeks after rHuEpo (58.065.6 mLNmin21Nkg21, p = 0.021). Hbmass was significantly increased at the end of administration compared to baseline (15.261.5 gNkg21 vs. 12.761.2 gNkg21, p,0.001). The rate of decrease in Hbmass toward baseline values post rHuEpo was similar to that of the increase during administration (20.53 gNkg21Nwk21, 95% confidence interval (CI) (20.68, 20.38) vs. 0.54 gNkg21Nwk21, CI (0.46, 0.63)) but Hbmass was still significantly elevated 4 weeks after administration compared to baseline (13.761.1 gNkg21, p<0.001).</p> <p>Conclusion: Running performance was improved following 4 weeks of rHuEpo and remained elevated 4 weeks after administration compared to baseline. These field performance effects coincided with rHuEpo-induced elevated v˙ O2 max and Hbmass.</p&gt

Health services changes: is a run-in period necessary before evaluation in randomised clinical trials?

Background Most randomised clinical trials (RCTs) testing a new health service do not allow a run-in period of consolidation before evaluating the new approach. Consequently, health professionals involved may feel insufficiently familiar or confident, or that new processes or systems that are integral to the service are insufficiently embedded in routine care prior to definitive evaluation in a RCT. This study aimed to determine the optimal run-in period for a new physiotherapy-led telephone assessment and treatment service known as PhysioDirect and whether a run-in was needed prior to evaluating outcomes in an RCT. Methods The PhysioDirect trial assessed whether PhysioDirect was as effective as usual care. Prior to the main trial, a run-in of up to 12 weeks was permitted to facilitate physiotherapists to become confident in delivering the new service. Outcomes collected from the run-in and main trial were length of telephone calls within the PhysioDirect service and patients’ physical function (SF-36v2 questionnaire) and Measure Yourself Medical Outcome Profile v2 collected at baseline and six months. Joinpoint regression determined how long it had taken call times to stabilise. Analysis of covariance determined whether patients’ physical function at six months changed from the run-in to the main trial. Results Mean PhysioDirect call times (minutes) were higher in the run-in (31 (SD: 12.6)) than in the main trial (25 (SD: 11.6)). Each physiotherapist needed to answer 42 (95% CI: 20,56) calls for their mean call time to stabilise at 25 minutes per call; this took a minimum of seven weeks. For patients’ physical function, PhysioDirect was equally clinically effective as usual care during both the run-in (0.17 (95% CI: -0.91,1.24)) and main trial (-0.01 (95% CI: -0.80,0.79)). Conclusions A run-in was not needed in a large trial testing PhysioDirect services in terms of patient outcomes. A learning curve was evident in the process measure of telephone call length. This decreased during the run-in and stabilised prior to commencement of the main trial. Future trials should build in a run-in if it is anticipated that learning would have an effect on patient outcome

Activity Increase Despite Arthritis (AÏDA): design of a Phase II randomised controlled trial evaluating an active management booklet for hip and knee osteoarthritis [ISRCTN24554946]

<p>Abstract</p> <p>Background</p> <p>Hip and knee osteoarthritis is a common cause of pain and disability, which can be improved by exercise interventions. However, regular exercise is uncommon in this group because the low physical activity level in the general population is probably reduced even further by pain related fear of movement. The best method of encouraging increased activity in this patient group is not known. A booklet has been developed for patients with hip or knee osteoarthritis. It focuses on changing disadvantageous beliefs and encouraging increased physical activity.</p> <p>Methods/Design</p> <p>This paper describes the design of a Phase II randomised controlled trial (RCT) to test the effectiveness of this new booklet for patients with hip and knee osteoarthritis in influencing illness and treatment beliefs, and to assess the feasibility of conducting a larger definitive RCT in terms of health status and exercise behaviour. A computerised search of four general medical practice patients' record databases will identify patients older than 50 years of age who have consulted with hip or knee pain in the previous twelve months. A random sample of 120 will be invited to participate in the RCT comparing the new booklet with a control booklet, and we expect 100 to return final questionnaires. This trial will assess the feasibility of recruitment and randomisation, the suitability of the control intervention and outcome measurement tools, and will provide an estimate of effect size. Outcomes will include beliefs about hip and knee pain, beliefs about exercise, fear avoidance, level of physical activity, health status and health service costs. They will be measured at baseline, one month and three months.</p> <p>Discussion</p> <p>We discuss the merits of testing effectiveness in a phase II trial, in terms of intermediate outcome measures, whilst testing the processes for a larger definitive trial. We also discuss the advantages and disadvantages of testing the psychometric properties of the primary outcome measures concurrently with the trial.</p> <p>Trial registration</p> <p>Current Controlled Trials ISRCTN24554946</p